FDA warns Curaleaf about inflated claims in CBD product marketing
4 years ago
19
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
1:09
WFTX
7 months agoLighthouse Beach to reopens amid county-wide swim advisory
340 -
0:42
KMGH
2 years agoBBB warns about travel scams
45 -
0:43
KMGH
2 years agoBBB warns about counterfeit items
44 -
0:53
KMGH
2 years agoBBB warns about weight loss supplements
11 -
1:14
Reuters
2 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
158 -
0:41
KMGH
2 years agoBBB warns about crypto message on Instagram
31 -
1:58
WFTS
2 years agoFBI warns about popular Facebook scam
83 -
1:28:55
Graham Allen
2 days agoRussell Brand Speaks Out On His Baptism......FINALLY Some Good News!!
155K401 -
1:10:02
CutJibNewsletter
3 days agoNo One is Above the Lore - Cut Jib Newsletter Speaks!
20.8K2 -
54:08
Real Coffee With Scott Adams
15 hours agoEpisode 2464 CWSA 05/04/24
83.5K99
